Volume 86 Issue 28 | p. 22 | Concentrates
Issue Date: July 14, 2008

Three Drug Majors Back Start-Up Enlight

Department: Business

Merck & Co., Pfizer, and Eli Lilly & Co. are the founding members of Enlight Biosciences, a new Boston-based company that seeks to advance technologies that accelerate drug discovery and development. Conceived by the three drug companies and the venture firm PureTech Ventures, Enlight will start with $39 million in funding. The partners note that most life sciences investors in recent years have focused on late-stage therapeutic programs to the detriment of new technology.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment